Experts, Lawmakers Explore Downside of Drug-Price Negotiation

Experts, Lawmakers Explore Downside of Drug-Price Negotiation https://www.medpagetoday.com/publichealthpolicy/medicare/107855 Stifled innovation, reduced access suggested as future challenges Potential unintended consequences of Medicare’s drug-price negotiation program were examined during a panel discussion hosted by The Hill and sponsored by the Alliance for Aging Research, an industry-funded nonprofit. Wednesday’s panelists raised concerns that drug-price negotiation under the Inflation […]

Georgia Medical Cannabis Officials Weigh Response To DEA Threat Against Pharmacies, Including Possible Lawsuit

I find it very interesting when one bureaucracy is going to sue another bureaucracy.  Especially when one bureaucracy’s action interferes with the ability to generate some revenue by another bureaucracy. Could this be a “backhanded”  process of the DEA’s wish to yank pharmacy’s DEA licenses so that there are few pharmacies in the state that […]